CLINICAL EVALUATION OF CEFUROXIME AXETIL (CXM-AX) IN THE FIELD OF UROLOGY

Cefuroxime axetil, a new oral cephalosporin, was administered at a daily dose of 500-1, 500 mg to patients with the urogenital infections. Clinical responses of 17 patients with acute uncomplicated cystitis were excellent in 14 and moderate in 3, and the overall effectiveness rate was 100%. In 15 pa...

Full description

Saved in:

Bibliographic Details
Published in:	CHEMOTHERAPY Vol. 34; no. Supplement5; pp. 661 - 668
Main Authors:	KISHI, HIROICHI, TOMINAGA, TAKASHI, NIIJIMA, TADAO, NISHIMURA, YOJI, ASANO, MICHIO, YUGE, JUNJI, SAITO, ISAO
Format:	Journal Article
Language:	English Japanese
Published:	Japanese Society of Chemotherapy 1986
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Cefuroxime axetil, a new oral cephalosporin, was administered at a daily dose of 500-1, 500 mg to patients with the urogenital infections. Clinical responses of 17 patients with acute uncomplicated cystitis were excellent in 14 and moderate in 3, and the overall effectiveness rate was 100%. In 15 patients with complicated urinary tract infection, excellent response was seen in 6, moderate response in 2 and poor response in 7, respectively, and overall effectiveness rate was 53%. N. gonorrhoeae was eradicated in all 4 patients with acute gonococcal urethritis and excellent response was taken in all. Effectiveness rates of 2 acute epididymitis and 14 chronic prostatitis were 100% and 50%, respectively. No significant side effects were observed clinically and conventional clinical laboratory tests showed no abnormalities related to the treatment.
ISSN:	0009-3165 1884-5894
DOI:	10.11250/chemotherapy1953.34.Supplement5_661